BR100 Decreased By (-0.02%)
BR30 Increased By (0.23%)
KSE100 Increased By (0.26%)
KSE30 Increased By (0.26%)
AGHA 7.60 Increased By ▲ 0.01 (0.13%)
BECO 5.56 Increased By ▲ 0.05 (0.91%)
BML 60.00 Increased By ▲ 0.92 (1.56%)
BOP 34.40 Increased By ▲ 0.29 (0.85%)
CNERGY 13.01 Increased By ▲ 0.17 (1.32%)
CSIL 6.40 Increased By ▲ 0.30 (4.92%)
FCCL 58.22 Increased By ▲ 0.56 (0.97%)
FFL 16.37 Increased By ▲ 0.17 (1.05%)
FNEL 1.22 Increased By ▲ 0.01 (0.83%)
KEL 7.44 Decreased By ▼ -0.04 (-0.53%)
KOSM 6.04 Increased By ▲ 0.10 (1.68%)
LOTCHEM 27.70 Decreased By ▼ -0.29 (-1.04%)
MLCF 102.43 Increased By ▲ 1.78 (1.77%)
NBP 204.75 Increased By ▲ 1.00 (0.49%)
NCPL 59.96 Decreased By ▼ -0.61 (-1.01%)
NPL 68.50 Decreased By ▼ -1.46 (-2.09%)
OGDC 318.80 Decreased By ▼ -1.49 (-0.47%)
PACE 11.00 Decreased By ▼ -0.10 (-0.9%)
PAEL 43.00 Decreased By ▼ -0.12 (-0.28%)
PIBTL 16.63 Increased By ▲ 0.07 (0.42%)
PPL 229.20 Increased By ▲ 0.36 (0.16%)
PRL 70.50 Decreased By ▼ -0.52 (-0.73%)
PTC 70.89 Decreased By ▼ -0.76 (-1.06%)
SSGC 27.39 Increased By ▲ 0.71 (2.66%)
TBL 10.35 Increased By ▲ 0.54 (5.5%)
TELE 8.50 Decreased By ▼ -0.11 (-1.28%)
TPL 23.11 Increased By ▲ 0.87 (3.91%)
TPLP 15.75 Increased By ▲ 0.64 (4.24%)
TREET 24.74 Increased By ▲ 0.61 (2.53%)
TRG 60.30 Increased By ▲ 0.46 (0.77%)
World

Labopharm explores various business options

Published Updated

candaTORONTO: Canadian biotechnology firm Labopharm Inc. said on Friday it was looking at various options for its assets and products, as well as exploring potential business combinations.

The company, which said last month it was viewing all strategic options, has entered into discussions with Italy's Gruppo Angelini, its U.S. partner, after a review of its effort to commercialize antidepressant Oleptro in the United States.

In March, Labopharm replaced its chief executive officer and cut its workforce.

Copyright Reuters, 2011

Comments

Comments are closed for this article.